Biotinylated Human TNFSF15 Protein (Primary Amine Labeling), Active
Beta LifeScience
SKU/CAT #: BLK-00118P-100UG

Biotinylated Human TNFSF15 on Tris-Bis PAGE under reduced condition. The purity is greater than 95%.
Biotinylated Human TNFSF15 Protein (Primary Amine Labeling), Active
Beta LifeScience
SKU/CAT #: BLK-00118P-100UG
Our products are highly customizable to meet your specific needs. You can choose options such as endotoxin removal, liquid or lyophilized forms, preferred tags, and the desired functional sequence range for proteins. Submitting a written inquiry expedites the quoting process.
Product Overview
Description | Recombinant Biotinylated Human TNFSF15 Protein (Primary Amine Labeling) is expressed from HEK293 with His tag at the N-terminus.It contains Leu72-Leu251. |
Purity | > 95% as determined by Tris-Bis PAGE;> 95% as determined by HPLC |
Accession | O95150 |
Target Symbol | TNFSF15 |
Species | Human |
Expression System | HEK293 |
Tag | N-His |
Expression Range | Leu72-Leu251 |
Mol. Weight | The protein has a predicted MW of 21.57 kDa. Due to glycosylation, the protein migrates to 25-35 kDa based on Tris-Bis PAGE result. |
Form | Lyophilized |
Formulation | Lyophilized from 0.22 um filtered solution in PBS (pH 7.4). Normally 8% trehalose is added as protectant before lyophilization. |
Endotoxin | Less than 1EU per ug by the LAL method. |
Activity | Immobilized Biotinylated Human TNFSF15, His Tag at 0.5ug/ml (100ul/well) on the streptavidin precoated plate (5ug/ml). Dose response curve for Anti-TNFSF15 Antibody, hFc Tag with the EC50 of 5.2ng/ml determined by ELISA. Contact us for detailed testing images. |
Storage | Reconstituted protein stable at -80°C for 12 months, 4°C for 1 week. Use a manual defrost freezer and avoid repeated freeze-thaw cycles. |
Shipping | Shipped at ambient temperature. |
Gene Background | TNF superfamily member 15 (TNFSF15), a cytokine largely produced by vascular endothelial cells and a specific inhibitor of the proliferation of these same cells, can inhibit VEGF-induced vascular permeability in vitro and in vivo, and that death receptor 3 (DR3), a cell surface receptor of TNFSF15, mediates TNFSF15-induced dephosphorylation of VEGFR2. |